Webinars
A Stagewise Approach to High Potency Drug Product Clinical Development & Commercialization
In this webinar, experts discuss how companies with promising HPAPIs can overcome development challenges in order to bring innovative medicines to market.
View Now
Webinars
Advanced Dosage Forms - Tackling Drug Delivery Challenges & Addressing Patient Needs
Summary: In this webinar, participants will both hear a panel of industry experts discuss practical challenges in oral drug development and gain valuable insights into current approaches to overcoming challenges in developing oral dosage forms that are more patient-friendly.
View Now
Executive Summary
Dosage Form Design and Patient Compliance-Exploring Orally Disintegrating Tablets as a Patient-Centric Solution
Summary: This article explores the needs of different patient groups, identifies frequent issues leading to non-compliance, looks at the role of orally disintegrating tablets (ODTs) in helping improve patient compliance, and provides examples of improving the delivery profile of the drug.
View Now
Executive Summary
PBPK Modelling for Optimizing Controlled Release Dosage Form Development
Summary: In this executive summary, we describe the benefits of controlled release, how to determine whether a drug is suitable for controlled release and more.
View Now
Webinars
Exploring Pectin and the Advancement of Delayed Release Technology
Summary: Experts provide an overview of why the properties and structure of pectin are well suited for site-specific delivery to the colon.
View Now
Video
Parallel Screening for Oral Delivery of Macromolecules
Summary: To rapidly screen macromolecules’ potential for oral delivery, it is critical to assess multiple enabling technologies in parallel, targeting different biological barriers.
View Now
Executive Summary
Mapping the Pathway to Designing Successful Treatments
This executive summary includes evidence on how the right guidance at the right time can help you create more successful treatments.
View Now
Offering Fact Sheet
OptiDose® Design Solution Capabilities Sheet
Summary: OptiDose Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led by Catalent’s highly experienced team of scientific advisors, this evaluation assesses key drug design considerations that can help create more successful treatments for all stakeholders.
View Now
Webinars
Use of PBPK Modeling for Predicting and Optimizing Controlled Release Dosage Forms
Summary: Experts will share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications.
View Now
Webinars
Strategies to Optimize the Dosage Form Design Process to Create Better Treatments
Summary: Experts use case studies to demonstrate how the right guidance, at the right time, can help drug developers create better treatments.
View Now